Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1985-4-12
|
| pubmed:abstractText |
Among 339,868 newborn infants screened at 3 weeks of age (91% compliance rate), 730 had elevated rates of excretion of cystine and the dibasic amino acids lysine, ornithine, and arginine; 191 infants had persistent "infantile cystinuria" on follow-up screening (100% compliance). Apparent incidence of the phenotype was 562 per million infants; this rate is seven times higher than for classic cystinuria in the adult segment of the Quebec population. We studied longitudinally 26 probands 2 to 4 months of age. Initially, each excreted cystine and dibasic amino acids at much higher levels than did normal infants or either parent. From parental phenotypes (heterozygous or homozygous normal) and urine amino acid excretion values at 6 months of age in probands, the infants were classified as either heterozygous for the various classic cystinuria genotypes--type I ("silent"), eight infants; type II (high excretor), three; type III (moderate excretor), nine--or homozygous (and genetic compound), six. Urine amino acid excretion diminished steadily with age, to reach the variant parental value in heterozygous infants but not in homozygotes. Cystinuria heterozygotes, with the possible exception of some type I individuals, could not be distinguished reliably from homozygotes in early infancy, although homozygotes had significantly higher excretion values as a group. We deduce that renal ontogeny amplifies phenotypic expression of cystinuria alleles, thus influencing correct classification of genotype (heterozygote vs homozygote, and type of allele). These findings have implications for counseling and the need for follow-up of infantile cystinuria.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0022-3476
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
106
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
411-6
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3919167-Aging,
pubmed-meshheading:3919167-Amino Acids,
pubmed-meshheading:3919167-Arginine,
pubmed-meshheading:3919167-Cystinuria,
pubmed-meshheading:3919167-Follow-Up Studies,
pubmed-meshheading:3919167-Genetic Counseling,
pubmed-meshheading:3919167-Genotype,
pubmed-meshheading:3919167-Humans,
pubmed-meshheading:3919167-Infant, Newborn,
pubmed-meshheading:3919167-Lysine,
pubmed-meshheading:3919167-Ornithine,
pubmed-meshheading:3919167-Phenotype,
pubmed-meshheading:3919167-Quebec
|
| pubmed:year |
1985
|
| pubmed:articleTitle |
Ontogeny modifies manifestations of cystinuria genes: implications for counseling.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|